Somerset Therapeutics Ltd. - Research Center
524758 WINTAC Group (XT) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Sep' 20 |
Jun' 20 |
Mar' 20 |
Dec' 19 |
Sep' 19 |
Sales |
44.93 |
30.05 |
29.19 |
20.53 |
17.57 |
Operating profit |
4.61 |
2.70 |
3.64 |
0.23 |
-1.94 |
Interest |
0.61 |
0.62 |
0.68 |
0.72 |
0.42 |
Gross profit |
4.06 |
2.12 |
4.41 |
0.65 |
-2.33 |
EPS (Rs) |
1.47 |
-0.32 |
1.23 |
-0.63 |
-3.33 |
Quarterly
results in details
|
Sep' 20 |
Jun' 20 |
Mar' 20 |
Dec' 19 |
Sep' 19 |
Other income |
0.06 |
0.05 |
1.44 |
1.13 |
0.03 |
Stock adjustment |
-0.02 |
-0.78 |
2.23 |
-2.06 |
-0.48 |
Raw material |
14.95 |
12.22 |
10.06 |
10.43 |
8.93 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
7.29 |
7.75 |
8.19 |
7.35 |
6.01 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
18.10 |
8.15 |
5.06 |
4.57 |
5.05 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
2.31 |
2.26 |
2.22 |
2.10 |
1.56 |
Taxation |
0.27 |
0.18 |
0.95 |
-0.82 |
-0.55 |
Net profit / loss |
1.47 |
-0.32 |
1.24 |
-0.63 |
-3.34 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
10.02 |
10.02 |
10.02 |
10.02 |
10.02 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
10.27 |
8.98 |
12.48 |
1.14 |
-11.04 |
GPM (%) |
9.02 |
7.06 |
14.39 |
2.98 |
-13.22 |
NPM (%) |
3.28 |
-1.05 |
4.04 |
-2.93 |
-18.98 |